Monday 20 August 2018

Clinical Gastro 2018!!

Hepatocellular carcinoma


Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer in adults, and is the most common cause of death in people with cirrhosis
It occurs in the setting of chronic liver inflammation, and is most closely linked to chronic viral hepatitis infection (hepatitis B or C) or exposure to toxins such as alcohol or aflatoxin. Certain diseases, such as hemochromatosis and alpha 1-antitrypsin deficiency, markedly increase the risk of developing HCC. Metabolic syndrome and NASH are also increasingly recognized as risk factors for HCC
As with any cancer, the treatment and prognosis of HCC vary depending on the specifics of tumor histology, size, how far the cancer has spread, and overall health.

Signs and symptoms


Most cases of HCC occur in people who already have signs and symptoms of chronic liver disease. They may present either with worsening of symptoms or may be without symptoms at the time of cancer detection. HCC may directly present with yellow skin, abdominal swelling due to fluid in the abdominal cavity, easy bruising from blood clotting abnormalitiesloss of appetite, unintentional weight loss, abdominal painnauseavomiting, or feeling tired

For more details visit : https://bit.ly/2mIEceL
Abstract submission : https://bit.ly/2Lm1yBd





No comments:

Post a Comment

13th International Conference on Clinical Gastroenterology and Hepatology June 19-20, 2019 - London, UK # ClinicalGastro2019   # Gastro...